Andrew Mok
Stock Analyst at Barclays
(3.46)
# 851
Out of 5,138 analysts
253
Total ratings
56.4%
Success rate
1.92%
Average return
Main Sectors:
Stocks Rated by Andrew Mok
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVAH Aveanna Healthcare Holdings | Maintains: Overweight | $9 → $11 | $9.68 | +13.64% | 3 | Jan 16, 2026 | |
| UNH UnitedHealth Group | Maintains: Overweight | $386 → $391 | $334.14 | +17.02% | 14 | Jan 5, 2026 | |
| MOH Molina Healthcare | Maintains: Underweight | $144 → $164 | $191.73 | -14.46% | 11 | Jan 5, 2026 | |
| HUM Humana | Maintains: Equal-Weight | $234 → $245 | $278.67 | -12.08% | 15 | Jan 5, 2026 | |
| ELV Elevance Health | Maintains: Overweight | $385 → $404 | $376.92 | +7.18% | 15 | Jan 5, 2026 | |
| CI The Cigna Group | Maintains: Overweight | $300 → $305 | $272.97 | +11.73% | 10 | Jan 5, 2026 | |
| OSCR Oscar Health | Upgrades: Equal-Weight | $13 → $18 | $17.00 | +5.88% | 4 | Jan 5, 2026 | |
| CNC Centene | Upgrades: Overweight | $44 → $54 | $46.40 | +16.38% | 13 | Jan 5, 2026 | |
| CVS CVS Health | Maintains: Overweight | $87 → $93 | $79.73 | +16.64% | 12 | Dec 10, 2025 | |
| ACHC Acadia Healthcare Company | Maintains: Equal-Weight | $17 → $14 | $11.63 | +20.38% | 19 | Dec 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $36 → $26 | $26.89 | -3.31% | 2 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $229 → $240 | $195.96 | +22.47% | 16 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $24 → $18 | $15.99 | +12.57% | 5 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $79 → $86 | $72.04 | +19.38% | 9 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $9.5 → $14 | $12.05 | +16.23% | 1 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $22 → $23 | $23.57 | -2.42% | 10 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $1.5 → $1 | $1.02 | -1.48% | 5 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $111 → $117 | $107.26 | +9.08% | 4 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $13 → $18 | $22.89 | -21.36% | 6 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $141 → $150 | $100.79 | +48.83% | 18 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $149 → $143 | $105.58 | +35.44% | 13 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $250 → $263 | $199.27 | +31.98% | 25 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $495 → $525 | $472.97 | +11.00% | 15 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $4 → $3.5 | $3.28 | +6.71% | 7 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $12 | $10.60 | +13.26% | 1 | Dec 8, 2022 |
Aveanna Healthcare Holdings
Jan 16, 2026
Maintains: Overweight
Price Target: $9 → $11
Current: $9.68
Upside: +13.64%
UnitedHealth Group
Jan 5, 2026
Maintains: Overweight
Price Target: $386 → $391
Current: $334.14
Upside: +17.02%
Molina Healthcare
Jan 5, 2026
Maintains: Underweight
Price Target: $144 → $164
Current: $191.73
Upside: -14.46%
Humana
Jan 5, 2026
Maintains: Equal-Weight
Price Target: $234 → $245
Current: $278.67
Upside: -12.08%
Elevance Health
Jan 5, 2026
Maintains: Overweight
Price Target: $385 → $404
Current: $376.92
Upside: +7.18%
The Cigna Group
Jan 5, 2026
Maintains: Overweight
Price Target: $300 → $305
Current: $272.97
Upside: +11.73%
Oscar Health
Jan 5, 2026
Upgrades: Equal-Weight
Price Target: $13 → $18
Current: $17.00
Upside: +5.88%
Centene
Jan 5, 2026
Upgrades: Overweight
Price Target: $44 → $54
Current: $46.40
Upside: +16.38%
CVS Health
Dec 10, 2025
Maintains: Overweight
Price Target: $87 → $93
Current: $79.73
Upside: +16.64%
Acadia Healthcare Company
Dec 4, 2025
Maintains: Equal-Weight
Price Target: $17 → $14
Current: $11.63
Upside: +20.38%
Nov 24, 2025
Maintains: Equal-Weight
Price Target: $36 → $26
Current: $26.89
Upside: -3.31%
Nov 21, 2025
Maintains: Overweight
Price Target: $229 → $240
Current: $195.96
Upside: +22.47%
Nov 21, 2025
Maintains: Equal-Weight
Price Target: $24 → $18
Current: $15.99
Upside: +12.57%
Nov 13, 2025
Maintains: Overweight
Price Target: $79 → $86
Current: $72.04
Upside: +19.38%
Nov 11, 2025
Upgrades: Overweight
Price Target: $9.5 → $14
Current: $12.05
Upside: +16.23%
Nov 10, 2025
Maintains: Equal-Weight
Price Target: $22 → $23
Current: $23.57
Upside: -2.42%
Nov 6, 2025
Maintains: Underweight
Price Target: $1.5 → $1
Current: $1.02
Upside: -1.48%
Nov 4, 2025
Maintains: Underweight
Price Target: $111 → $117
Current: $107.26
Upside: +9.08%
Nov 3, 2025
Maintains: Equal-Weight
Price Target: $13 → $18
Current: $22.89
Upside: -21.36%
Oct 30, 2025
Maintains: Overweight
Price Target: $141 → $150
Current: $100.79
Upside: +48.83%
Oct 30, 2025
Maintains: Equal-Weight
Price Target: $149 → $143
Current: $105.58
Upside: +35.44%
Oct 28, 2025
Maintains: Overweight
Price Target: $250 → $263
Current: $199.27
Upside: +31.98%
Oct 27, 2025
Maintains: Buy
Price Target: $495 → $525
Current: $472.97
Upside: +11.00%
Jul 24, 2025
Maintains: Equal-Weight
Price Target: $4 → $3.5
Current: $3.28
Upside: +6.71%
Dec 8, 2022
Initiates: Sell
Price Target: $12
Current: $10.60
Upside: +13.26%